{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:37:55Z","timestamp":1791185875459,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,11,11]],"date-time":"2011-11-11T00:00:00Z","timestamp":1320969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2011.39","type":"journal-article","created":{"date-parts":[[2011,11,11]],"date-time":"2011-11-11T15:20:45Z","timestamp":1321024845000},"page":"e40-e40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms"],"prefix":"10.1038","volume":"1","author":[{"given":"K L","family":"Rice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Wolniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B L","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Berkofsky-Fessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Buzzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Elkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Golub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D G","family":"Gilliland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J D","family":"Crispino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J D","family":"Licht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,11]]},"reference":[{"key":"BFbcj201139_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12185-010-0530-z","volume":"91","author":"F Delhommeau","year":"2010","unstructured":"Delhommeau F, Jeziorowska D, Marzac C, Casadevall N . Molecular aspects of myeloproliferative neoplasms. Int J Hematol 2010; 91: 165\u2013173.","journal-title":"Int J Hematol"},{"key":"BFbcj201139_CR2","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/leu.2010.69","volume":"24","author":"A Tefferi","year":"2010","unstructured":"Tefferi A . Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 2010; 24: 1128\u20131138.","journal-title":"Leukemia"},{"key":"BFbcj201139_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gde.2006.12.009","volume":"17","author":"JN Ihle","year":"2007","unstructured":"Ihle JN, Gilliland DG . Jak2: normal function and role in hematopoietic disorders. Curr Opin Genet Dev 2007; 17: 8\u201314.","journal-title":"Curr Opin Genet Dev"},{"key":"BFbcj201139_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0952-7915(98)80165-9","volume":"10","author":"KD Liu","year":"1998","unstructured":"Liu KD, Gaffen SL, Goldsmith MA . JAK\/STAT signaling by cytokine receptors. Curr Opin Immunol 1998; 10: 271\u2013278.","journal-title":"Curr Opin Immunol"},{"key":"BFbcj201139_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev.med.59.061506.154159","volume":"59","author":"KJ Morgan","year":"2008","unstructured":"Morgan KJ, Gilliland DG . A role for JAK2 mutations in myeloproliferative diseases. Annu Rev Med 2008; 59: 213\u2013222.","journal-title":"Annu Rev Med"},{"key":"BFbcj201139_CR6","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144\u20131148.","journal-title":"Nature"},{"key":"BFbcj201139_CR7","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1182\/blood-2005-05-1889","volume":"106","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Teo SS, Buser AS, Brutsche M, Tiedt R, Tichelli A et al. Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2. Blood 2005; 106: 3374\u20133376.","journal-title":"Blood"},{"key":"BFbcj201139_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"RL Levine","year":"2005","unstructured":"Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 2005; 7: 387\u2013397.","journal-title":"Cancer Cell"},{"key":"BFbcj201139_CR9","doi-asserted-by":"publisher","first-page":"22788","DOI":"10.1074\/jbc.C500138200","volume":"280","author":"R Zhao","year":"2005","unstructured":"Zhao R, Xing S, Li Z, Fu X, Li Q, Krantz SB et al. Identification of an acquired JAK2 mutation in polycythemia vera. J Biol Chem 2005; 280: 22788\u201322792.","journal-title":"J Biol Chem"},{"key":"BFbcj201139_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1182\/blood-2006-12-062125","volume":"110","author":"A Theocharides","year":"2007","unstructured":"Theocharides A, Boissinot M, Girodon F, Garand R, Teo SS, Lippert E et al. Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation. Blood 2007; 110: 375\u2013379.","journal-title":"Blood"},{"key":"BFbcj201139_CR11","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A et al. Mutation in TET2 in myeloid cancers. N Engl J Med 2009; 360: 2289\u20132301.","journal-title":"N Engl J Med"},{"key":"BFbcj201139_CR12","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","volume":"145","author":"V Gelsi-Boyer","year":"2009","unstructured":"Gelsi-Boyer V, Trouplin V, Adelaide J, Bonansea J, Cervera N, Carbuccia N et al. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol 2009; 145: 788\u2013800.","journal-title":"Br J Haematol"},{"key":"BFbcj201139_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJMc0910063","volume":"362","author":"A Green","year":"2010","unstructured":"Green A, Beer P . Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms. N Engl J Med 2010; 362: 369\u2013370.","journal-title":"N Engl J Med"},{"key":"BFbcj201139_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1046\/j.1365-2141.2001.02796.x","volume":"113","author":"A Tefferi","year":"2001","unstructured":"Tefferi A, Mesa RA, Schroeder G, Hanson CA, Li CY, Dewald GW . Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia. Br J Haematol 2001; 113: 763\u2013771.","journal-title":"Br J Haematol"},{"key":"BFbcj201139_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000064754","volume":"108","author":"DP Steensma","year":"2002","unstructured":"Steensma DP, Tefferi A . Cytogenetic and molecular genetic aspects of essential thrombocythemia. Acta Haematol 2002; 108: 55\u201365.","journal-title":"Acta Haematol"},{"key":"BFbcj201139_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1600-0609.2007.01003.x","volume":"80","author":"N Gangat","year":"2008","unstructured":"Gangat N, Strand J, Lasho TL, Finke CM, Knudson RA, Pardanani A et al. Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates. Eur J Haematol 2008; 80: 197\u2013200.","journal-title":"Eur J Haematol"},{"key":"BFbcj201139_CR17","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.leukres.2008.09.009","volume":"33","author":"A Tefferi","year":"2009","unstructured":"Tefferi A, Sirhan S, Sun Y, Lasho T, Finke CM, Weisberger J et al. Oligonucleotide array CGH studies in myeloproliferative neoplasms: comparison with JAK2V617F mutational status and conventional chromosome analysis. Leuk Res 2009; 33: 662\u2013664.","journal-title":"Leuk Res"},{"key":"BFbcj201139_CR18","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ng.391","volume":"41","author":"SM Langemeijer","year":"2009","unstructured":"Langemeijer SM, Kuiper RP, Berends M, Knops R, Aslanyan MG, Massop M et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet 2009; 41: 838\u2013842.","journal-title":"Nat Genet"},{"key":"BFbcj201139_CR19","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","volume":"446","author":"CG Mullighan","year":"2007","unstructured":"Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446: 758\u2013764.","journal-title":"Nature"},{"key":"BFbcj201139_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1182\/blood-2011-01-331678","volume":"118","author":"T Klampfl","year":"2011","unstructured":"Klampfl T, Harutyunyan A, Berg T, Gisslinger B, Schalling M, Bagienski K et al. Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression. Blood 2011; 118: 167\u2013176.","journal-title":"Blood"},{"key":"BFbcj201139_CR21","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1182\/blood-2005-09-3900","volume":"107","author":"RL Levine","year":"2006","unstructured":"Levine RL, Belisle C, Wadleigh M, Zahrieh D, Lee S, Chagnon P et al. X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET\/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis. Blood 2006; 107: 4139\u20134141.","journal-title":"Blood"},{"key":"BFbcj201139_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/biostatistics\/kxh008","volume":"5","author":"AB Olshen","year":"2004","unstructured":"Olshen AB, Venkatraman ES, Lucito R, Wigler M . Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004; 5: 557\u2013572.","journal-title":"Biostatistics"},{"key":"BFbcj201139_CR23","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1371\/journal.pcbi.0020041","volume":"2","author":"R Beroukhim","year":"2006","unstructured":"Beroukhim R, Lin M, Park Y, Hao K, Zhao X, Garraway LA et al. Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays. PLoS Comput Biol 2006; 2: e41.","journal-title":"PLoS Comput Biol"},{"key":"BFbcj201139_CR24","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1158\/1078-0432.CCR-10-1092","volume":"16","author":"W Berkofsky-Fessler","year":"2010","unstructured":"Berkofsky-Fessler W, Buzzai M, Kim MK, Fruchtman S, Najfeld V, Min DJ et al. Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F. Clin Cancer Res 2010; 16: 4339\u20134352.","journal-title":"Clin Cancer Res"},{"key":"BFbcj201139_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1634\/stemcells.2006-0351","volume":"25","author":"P Guglielmelli","year":"2007","unstructured":"Guglielmelli P, Zini R, Bogani C, Salati S, Pancrazzi A, Bianchi E et al. Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms\u2019 tumor gene 1 (WT1). Stem Cells 2007; 25: 165\u2013173.","journal-title":"Stem Cells"},{"key":"BFbcj201139_CR26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1160\/TH05-01-0037","volume":"94","author":"DV Gnatenko","year":"2005","unstructured":"Gnatenko DV, Cupit LD, Huang EC, Dhundale A, Perrotta PL, Bahou WF . Platelets express steroidogenic 17beta-hydroxysteroid dehydrogenases. Distinct profiles predict the essential thrombocythemic phenotype. Thromb Haemost 2005; 94: 412\u2013421.","journal-title":"Thromb Haemost"},{"key":"BFbcj201139_CR27","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1182\/blood-2003-07-2597","volume":"104","author":"E Tenedini","year":"2004","unstructured":"Tenedini E, Fagioli ME, Vianelli N, Tazzari PL, Ricci F, Tagliafico E et al. Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells. Blood 2004; 104: 3126\u20133135.","journal-title":"Blood"},{"key":"BFbcj201139_CR28","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1128\/MCB.11.4.1980","volume":"11","author":"AD D\u2019Andrea","year":"1991","unstructured":"D\u2019Andrea AD, Yoshimura A, Youssoufian H, Zon LI, Koo JW, Lodish HF . The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol Cell Biol 1991; 11: 1980\u20131987.","journal-title":"Mol Cell Biol"},{"key":"BFbcj201139_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3324\/haematol.2009.013623","volume":"95","author":"F Stegelmann","year":"2010","unstructured":"Stegelmann F, Bullinger L, Griesshammer M, Holzmann K, Habdank M, Kuhn S et al. High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations. Haematologica 2010; 95: 666\u2013669.","journal-title":"Haematologica"},{"key":"BFbcj201139_CR30","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1038\/leu.2009.141","volume":"23","author":"N Carbuccia","year":"2009","unstructured":"Carbuccia N, Murati A, Trouplin V, Brecqueville M, Adelaide J, Rey J et al. Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia 2009; 23: 2183\u20132186.","journal-title":"Leukemia"},{"key":"BFbcj201139_CR31","doi-asserted-by":"publisher","first-page":"e8785","DOI":"10.1371\/journal.pone.0008785","volume":"5","author":"EC Forsberg","year":"2010","unstructured":"Forsberg EC, Passegue E, Prohaska SS, Wagers AJ, Koeva M, Stuart JM et al. Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells. PLoS One 2010; 5: e8785.","journal-title":"PLoS One"},{"key":"BFbcj201139_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.molmed.2005.10.003","volume":"11","author":"C James","year":"2005","unstructured":"James C, Ugo V, Casadevall N, Constantinescu SN, Vainchenker W . A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects. Trends Mol Med 2005; 11: 546\u2013554.","journal-title":"Trends Mol Med"},{"key":"BFbcj201139_CR33","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1182\/blood-2006-04-018259","volume":"108","author":"LM Scott","year":"2006","unstructured":"Scott LM, Scott MA, Campbell PJ, Green AR . Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. Blood 2006; 108: 2435\u20132437.","journal-title":"Blood"},{"key":"BFbcj201139_CR34","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/leu.2010.69","volume":"24","author":"A Tefferi","year":"2010","unstructured":"Tefferi A . Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 2010; 24: 1128\u20131138.","journal-title":"Leukemia"},{"key":"BFbcj201139_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0092-8674(00)00027-1","volume":"102","author":"K Tamura","year":"2000","unstructured":"Tamura K, Sudo T, Senftleben U, Dadak AM, Johnson R, Karin M . Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 2000; 102: 221\u2013231.","journal-title":"Cell"},{"key":"BFbcj201139_CR36","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1182\/blood-2007-08-107748","volume":"111","author":"R Tiedt","year":"2008","unstructured":"Tiedt R, Hao-Shen H, Sobas MA, Looser R, Dirnhofer S, Schwaller J et al. Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice. Blood 2008; 111: 3931\u20133940.","journal-title":"Blood"},{"key":"BFbcj201139_CR37","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.semcdb.2008.07.010","volume":"19","author":"BA Croker","year":"2008","unstructured":"Croker BA, Kiu H, Nicholson SE . SOCS regulation of the JAK\/STAT signalling pathway. Semin Cell Dev Biol 2008; 19: 414\u2013422.","journal-title":"Semin Cell Dev Biol"},{"key":"BFbcj201139_CR38","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1182\/blood.V95.12.3765","volume":"95","author":"JJ Schuringa","year":"2000","unstructured":"Schuringa JJ, Wierenga AT, Kruijer W, Vellenga E . Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6. Blood 2000; 95: 3765\u20133770.","journal-title":"Blood"},{"key":"BFbcj201139_CR39","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1182\/blood-2006-08-039735","volume":"109","author":"MB Hookham","year":"2007","unstructured":"Hookham MB, Elliott J, Suessmuth Y, Staerk J, Ward AC, Vainchenker W et al. The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3. Blood 2007; 109: 4924\u20134929.","journal-title":"Blood"},{"key":"BFbcj201139_CR40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0301-472X(01)00789-5","volume":"30","author":"R Kralovics","year":"2002","unstructured":"Kralovics R, Guan Y, Prchal JT . Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Exp Hematol 2002; 30: 229\u2013236.","journal-title":"Exp Hematol"},{"key":"BFbcj201139_CR41","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1182\/blood-2003-03-0744","volume":"102","author":"R Kralovics","year":"2003","unstructured":"Kralovics R, Buser AS, Teo SS, Coers J, Tichelli A, van der Maas AP et al. Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders. Blood 2003; 102: 1869\u20131871.","journal-title":"Blood"},{"key":"BFbcj201139_CR42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/leu.2008.228","volume":"23","author":"F Bernard","year":"2009","unstructured":"Bernard F, Gelsi-Boyer V, Murati A, Giraudier S, Trouplin V, Adelaide J et al. Alterations of NFIA in chronic malignant myeloid diseases. Leukemia 2009; 23: 583\u2013585.","journal-title":"Leukemia"},{"key":"BFbcj201139_CR43","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.stem.2008.01.013","volume":"2","author":"C Pina","year":"2008","unstructured":"Pina C, May G, Soneji S, Hong D, Enver T . MLLT3 regulates early human erythroid and megakaryocytic cell fate. Cell Stem Cell 2008; 2: 264\u2013273.","journal-title":"Cell Stem Cell"},{"key":"BFbcj201139_CR44","first-page":"3085","volume":"8","author":"S Iida","year":"1993","unstructured":"Iida S, Seto M, Yamamoto K, Komatsu H, Tojo A, Asano S et al. MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine\/proline rich protein homologous to MLLT1 on 19p13. Oncogene 1993; 8: 3085\u20133092.","journal-title":"Oncogene"},{"key":"BFbcj201139_CR45","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2008.10.016","volume":"32","author":"X Shen","year":"2008","unstructured":"Shen X, Liu Y, Hsu YJ, Fujiwara Y, Kim J, Mao X et al. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol Cell 2008; 32: 491\u2013502.","journal-title":"Mol Cell"},{"key":"BFbcj201139_CR46","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nature08448","volume":"461","author":"MA Dawson","year":"2009","unstructured":"Dawson MA, Bannister AJ, Gottgens B, Foster SD, Bartke T, Green AR et al. JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature 2009; 461: 819\u2013822.","journal-title":"Nature"},{"key":"BFbcj201139_CR47","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1182\/blood-2008-01-134114","volume":"112","author":"I Plo","year":"2008","unstructured":"Plo I, Nakatake M, Malivert L, de Villartay JP, Giraudier S, Villeval JL et al. JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders. Blood 2008; 112: 1402\u20131412.","journal-title":"Blood"},{"key":"BFbcj201139_CR48","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1182\/blood-2009-07-235119","volume":"115","author":"NH Thoennissen","year":"2010","unstructured":"Thoennissen NH, Krug UO, Lee DH, Kawamata N, Iwanski GB, Lasho T et al. Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms. Blood 2010; 115: 2882\u20132890.","journal-title":"Blood"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bcj201139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bcj201139","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T02:26:23Z","timestamp":1686450383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,11]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,11]]}},"alternative-id":["BFbcj201139"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2011.39","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,11]]},"assertion":[{"value":"16 June 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}